Intensity modulated photon and proton therapy for the treatment of head and neck tumors

被引:130
作者
Steneker, Marloes
Lomax, Antony
Schneider, Uwe
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Div Med Phys, NL-1066 CX Amsterdam, Netherlands
[2] Paul Scherrer Inst, Dept Radiat Med, CH-5232 Villigen, Switzerland
[3] Univ Groningen, NL-9700 AB Groningen, Netherlands
[4] City Hosp Triemli, Dept Radiat Oncol & Nucl Med, Div Med Phys, Zurich, Switzerland
关键词
IMRT; proton therapy and secondary cancer;
D O I
10.1016/j.radonc.2006.07.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A comparative treatment planning study has been performed between intensity modulated photon and proton therapy to investigate the ability of both modalities to spare organs at risk in the head and neck region while keeping target dose homogeneous. Additional advantage of reducing the spot size for IMPT was also investigated. The treatment planning comparison was extended by varying the number of fields to study its effect on the performance of each modality. Risks of secondary cancer induction were also calculated for all modalities. Materials and methods: Five planning CTs were selected for the study. Four different constraints were set to the organs at risk in order to measure the resulting dose homogeneity in the target volume. Five and nine field plans were made for IMXT and 3, 5 and 9 field plans were made for IMPT, for both spot sizes. Dose homogeneity as a function of the mean parotid dose was visualized using a 'pseudo' Pareto-optimal front approach. Risks of secondary cancer were estimated using the organ equivalent dose model. Results: Critical organs were best spared using 3-field IMPT and, at least for IMPT, little advantage was seen with increasing field numbers. Reducing the spot size does give an advantage. In contrast, there was a significant advantage in going from 5 to 9 fields for IMXT. Secondary cancer risk was lowest for the IMPT plans with reduced spot size, for which normal tissue received the lowest integral dose. Interestingly, although integral dose remained the same, increasing the number of IMPT fields increased the secondary cancer risk, due to the increased volume of tissue irradiated to low dose. Conclusions: IMPT has a better ability to spare organs at risk than IMXT for the same dose homogeneity. It also significantly reduced the estimated risk of secondary cancer induction and the use of small numbers of fields further increased this advantage. Given that target homogeneity and normal tissue sparing were equally good with the 3 field IMPT, there appears to be a clear rationale to deliver small numbers of fields for IMPT. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 11 条
  • [1] A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours
    Cozzi, L
    Fogliata, A
    Lomax, A
    Bolsi, A
    [J]. RADIOTHERAPY AND ONCOLOGY, 2001, 61 (03) : 287 - 297
  • [2] Radiation-induced second cancers: The impact of 3D-CRT and IMRT
    Hall, EJ
    Wuu, CS
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 83 - 88
  • [3] Intensity modulation methods for proton radiotherapy
    Lomax, A
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 1999, 44 (01) : 185 - 205
  • [4] Treatment planning and verification of proton therapy using spot scanning:: Initial experiences
    Lomax, AJ
    Böhringer, T
    Bolsi, A
    Coray, D
    Emert, F
    Goitein, G
    Jermann, M
    Lin, SX
    Pedroni, E
    Rutz, H
    Stadelmann, O
    Timmermann, B
    Verwey, J
    Weber, DC
    [J]. MEDICAL PHYSICS, 2004, 31 (11) : 3150 - 3157
  • [5] A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy
    Lomax, AJ
    Bortfeld, T
    Goitein, G
    Debus, J
    Dykstra, C
    Tercier, PA
    Coucke, PA
    Mirimanoff, RO
    [J]. RADIOTHERAPY AND ONCOLOGY, 1999, 51 (03) : 257 - 271
  • [6] THE 200-MEV PROTON THERAPY PROJECT AT THE PAUL-SCHERRER-INSTITUTE - CONCEPTUAL DESIGN AND PRACTICAL REALIZATION
    PEDRONI, E
    BACHER, R
    BLATTMANN, H
    BOHRINGER, T
    CORAY, A
    LOMAX, A
    LIN, SX
    MUNKEL, G
    SCHEIB, S
    SCHNEIDER, U
    TOUROVSKY, A
    [J]. MEDICAL PHYSICS, 1995, 22 (01) : 37 - 53
  • [7] Pedroni Eros, 2004, Z Med Phys, V14, P25
  • [8] Neutron dose from prostheses material during radiotherapy with protons and photons
    Schneider, U
    Fiechtner, A
    Besserer, J
    Lomax, A
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2004, 49 (09) : N119 - N124
  • [9] Radiation induced cancer after radiotherapy: The impact of IMRT and proton radiotherapy
    Schneider, U
    Lomax, A
    Pemler, P
    Besserer, J
    Ross, D
    Lombriser, N
    Kaser-Hotz, B
    [J]. MEDICAL PHYSICS, 2005, 32 (06) : 1969 - 1969
  • [10] Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose
    Schneider, U
    Zwahlen, D
    Ross, D
    Kaser-Hotz, B
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05): : 1510 - 1515